UniQure stock catapulted Wednesday after the company said its experimental gene therapy successfully treated Huntington's disease.
UniQure (QURE) stock catapulted more than 200% Wednesday after the company said its experimental gene therapy successfully treated Huntington's disease.
Huntington's disease is a neurological condition that slowly destroys brain cells, robbing patien... [2474 chars]